Ignite Creation Date:
2025-12-24 @ 6:31 PM
Ignite Modification Date:
2026-01-02 @ 5:53 PM
Study NCT ID:
NCT02455557
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-10
First Post:
2015-05-22
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
Sponsor:
Roswell Park Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-05-04
Start Date Type:
ACTUAL
Primary Completion Date:
2019-10-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-11-30
Completion Date Type:
ESTIMATED
First Submit Date:
2015-05-22
First Submit QC Date:
None
Study First Post Date:
2015-05-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-12-17
Results First Submit QC Date:
None
Results First Post Date:
2021-02-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-30
Last Update Post Date:
2025-10-10
Last Update Post Date Type:
ESTIMATED